Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 139

1.

Effect of opioid-substitution therapy and mental health counseling on HIV risk among hepatitis C-infected individuals.

Butt ZA, Shrestha N, Gesink D, Murti M, Buxton JA, Gilbert M, Balshaw RF, Wong S, Kuo M, Wong J, Yu A, Alvarez M, Samji H, Roth D, Consolacion T, Hull MW, Ogilvie G, Tyndall MW, Krajden M, Janjua NZ.

Clin Epidemiol. 2018 Aug 31;10:1127-1145. doi: 10.2147/CLEP.S173449. eCollection 2018.

2.

Hepatitis C virus reinfection after successful treatment with direct-acting antiviral therapy in a large population-based cohort.

Rossi C, Butt ZA, Wong S, Buxton JA, Islam N, Yu A, Darvishian M, Gilbert M, Wong J, Chapinal N, Binka M, Alvarez M, Tyndall MW, Krajden M, Janjua NZ; BC Hepatitis Testers Cohort Team.

J Hepatol. 2018 Nov;69(5):1007-1014. doi: 10.1016/j.jhep.2018.07.025. Epub 2018 Aug 22.

PMID:
30142429
3.

Identifying injection drug use and estimating population size of people who inject drugs using healthcare administrative datasets.

Janjua NZ, Islam N, Kuo M, Yu A, Wong S, Butt ZA, Gilbert M, Buxton J, Chapinal N, Samji H, Chong M, Alvarez M, Wong J, Tyndall MW, Krajden M; BC Hepatitis Testers Cohort Team.

Int J Drug Policy. 2018 May;55:31-39. doi: 10.1016/j.drugpo.2018.02.001. Epub 2018 Feb 23.

PMID:
29482150
4.

Hepatitis C cross-genotype immunity and implications for vaccine development.

Islam N, Krajden M, Shoveller J, Gustafson P, Gilbert M, Wong J, Tyndall MW, Janjua NZ; The BC-HTC Team.

Sci Rep. 2017 Sep 26;7(1):12326. doi: 10.1038/s41598-017-10190-8.

5.

A syndemic approach to assess the effect of substance use and social disparities on the evolution of HIV/HCV infections in British Columbia.

Butt ZA, Shrestha N, Wong S, Kuo M, Gesink D, Gilbert M, Wong J, Yu A, Alvarez M, Samji H, Buxton JA, Johnston JC, Cook VJ, Roth D, Consolacion T, Murti M, Hottes TS, Ogilvie G, Balshaw R, Tyndall MW, Krajden M, Janjua NZ; BC Hepatitis Testers Cohort.

PLoS One. 2017 Aug 22;12(8):e0183609. doi: 10.1371/journal.pone.0183609. eCollection 2017.

6.

Incidence, risk factors, and prevention of hepatitis C reinfection: a population-based cohort study.

Islam N, Krajden M, Shoveller J, Gustafson P, Gilbert M, Buxton JA, Wong J, Tyndall MW, Janjua NZ; British Columbia Hepatitis Testers Cohort (BC-HTC) team.

Lancet Gastroenterol Hepatol. 2017 Mar;2(3):200-210. doi: 10.1016/S2468-1253(16)30182-0. Epub 2016 Dec 23. Erratum in: Lancet Gastroenterol Hepatol. 2017 Mar;2(3):e2.

PMID:
28404135
7.

Uptake of Community-Based Peer Administered HIV Point-of-Care Testing: Findings from the PROUD Study.

Lazarus L, Patel S, Shaw A, Leblanc S, Lalonde C, Hladio M, Mandryk K, Horvath C, Petrcich W, Kendall C, Tyndall MW; Proud Community Advisory Committee.

PLoS One. 2016 Dec 2;11(12):e0166942. doi: 10.1371/journal.pone.0166942. eCollection 2016.

8.

Role of primary T-cell immunodeficiency and hepatitis B coinfection on spontaneous clearance of hepatitis C: The BC Hepatitis Testers Cohort.

Islam N, Krajden M, Gilbert M, Gustafson P, Yu A, Kuo M, Chong M, Alvarez M, Wong J, Tyndall MW, Janjua NZ.

J Viral Hepat. 2017 May;24(5):421-429. doi: 10.1111/jvh.12650. Epub 2016 Nov 25.

PMID:
27885757
9.

Twin epidemics of new and prevalent hepatitis C infections in Canada: BC Hepatitis Testers Cohort.

Janjua NZ, Yu A, Kuo M, Alvarez M, Cook D, Wong J, Tyndall MW, Krajden M.

BMC Infect Dis. 2016 Jul 19;16:334. doi: 10.1186/s12879-016-1683-z.

10.

Assessing Hepatitis C Burden and Treatment Effectiveness through the British Columbia Hepatitis Testers Cohort (BC-HTC): Design and Characteristics of Linked and Unlinked Participants.

Janjua NZ, Kuo M, Chong M, Yu A, Alvarez M, Cook D, Armour R, Aiken C, Li K, Mussavi Rizi SA, Woods R, Godfrey D, Wong J, Gilbert M, Tyndall MW, Krajden M.

PLoS One. 2016 Mar 8;11(3):e0150176. doi: 10.1371/journal.pone.0150176. eCollection 2016.

11.

Cannabis vaping and public health--some comments on relevance and implications.

Fischer B, Russell C, Tyndall MW.

Addiction. 2015 Nov;110(11):1705-6. doi: 10.1111/add.13064.

PMID:
26471151
12.

Planning for the Next Global Pandemic.

Ross AG, Crowe SM, Tyndall MW.

Int J Infect Dis. 2015 Sep;38:89-94. doi: 10.1016/j.ijid.2015.07.016. Epub 2015 Aug 4.

13.

Establishing a community-based participatory research partnership among people who use drugs in Ottawa: the PROUD cohort study.

Lazarus L, Shaw A, LeBlanc S, Martin A, Marshall Z, Weersink K, Lin D, Mandryk K, Tyndall MW; PROUD Community Advisory Committee.

Harm Reduct J. 2014 Oct 13;11(1):26. doi: 10.1186/1477-7517-11-26.

14.

Individual and jurisdictional factors associated with voluntary HIV testing in Canada: Results of a national survey, 2011.

Worthington CA, Calzavara LM, White SJ, Allman D, Tyndall MW.

Can J Public Health. 2014 Nov 6;106(2):e4-9. doi: 10.17269/rcsp.106.4625.

PMID:
25955665
15.

Continued low uptake of treatment for hepatitis C virus infection in a large community-based cohort of inner city residents.

Alavi M, Raffa JD, Deans GD, Lai C, Krajden M, Dore GJ, Tyndall MW, Grebely J.

Liver Int. 2014 Sep;34(8):1198-206. doi: 10.1111/liv.12370. Epub 2013 Nov 20.

PMID:
24164865
16.

Mortality in a large community-based cohort of inner-city residents in Vancouver, Canada.

Deans GD, Raffa JD, Lai C, Fischer B, Krajden M, Amin J, Walter SR, Dore GJ, Grebely J, Tyndall MW.

CMAJ Open. 2013 May 23;1(2):E68-76. doi: 10.9778/cmajo.20130002. eCollection 2013 May.

17.

The role of diet in predicting iron deficiency anemia in HIV-positive women.

Renouf LS, Sheps S, Hubley A, Pick N, Johansen D, Tyndall MW.

Can J Diet Pract Res. 2012 Fall;73(3):128-33.

PMID:
22958630
18.

A dose-response relationship between exposure to a large-scale HIV preventive intervention and consistent condom use with different sexual partners of female sex workers in southern India.

Deering KN, Boily MC, Lowndes CM, Shoveller J, Tyndall MW, Vickerman P, Bradley J, Gurav K, Pickles M, Moses S, Ramesh BM, Washington R, Rajaram S, Alary M.

BMC Public Health. 2011 Dec 29;11 Suppl 6:S8. doi: 10.1186/1471-2458-11-S6-S8.

19.

Occupational stigma as a primary barrier to health care for street-based sex workers in Canada.

Lazarus L, Deering KN, Nabess R, Gibson K, Tyndall MW, Shannon K.

Cult Health Sex. 2012;14(2):139-50. doi: 10.1080/13691058.2011.628411. Epub 2011 Nov 15.

20.

Management of HCV and HIV infections among people who inject drugs.

Grebely J, Tyndall MW.

Curr Opin HIV AIDS. 2011 Nov;6(6):501-7. doi: 10.1097/COH.0b013e32834bcb36. Review.

PMID:
22001894
21.

The street cost of drugs and drug use patterns: relationships with sex work income in an urban Canadian setting.

Deering KN, Shoveller J, Tyndall MW, Montaner JS, Shannon K.

Drug Alcohol Depend. 2011 Nov 1;118(2-3):430-6. doi: 10.1016/j.drugalcdep.2011.05.005. Epub 2011 Jun 24.

22.

Individual and structural vulnerability among female youth who exchange sex for survival.

Miller CL, Fielden SJ, Tyndall MW, Zhang R, Gibson K, Shannon K.

J Adolesc Health. 2011 Jul;49(1):36-41. doi: 10.1016/j.jadohealth.2010.10.003. Epub 2011 May 26.

23.

Factors associated with numbers of client partners of female sex workers across five districts in South India.

Deering KN, Tyndall MW, Shoveller J, Moses S, Blanchard JF, Shaw S, Ramesh BM, Isac S, Boily MC.

Sex Transm Dis. 2010 Nov;37(11):687-95. doi: 10.1097/OLQ.0b013e3181ecfeeb.

PMID:
20975483
24.

Regional patterns of risk for sexually transmitted infections in British Columbia.

Deering KN, Tyndall MW, Koehoorn M.

Health Rep. 2010 Sep;21(3):37-44.

25.

A peer-led mobile outreach program and increased utilization of detoxification and residential drug treatment among female sex workers who use drugs in a Canadian setting.

Deering KN, Kerr T, Tyndall MW, Montaner JS, Gibson K, Irons L, Shannon K.

Drug Alcohol Depend. 2011 Jan 1;113(1):46-54. doi: 10.1016/j.drugalcdep.2010.07.007. Epub 2010 Aug 21.

PMID:
20727683
26.

Challenges in initiating antiretroviral therapy in 2010.

Tremblay CL, Baril JG, Fletcher D, Kilby D, Macpherson P, Shafran SD, Tyndall MW.

Can J Infect Dis Med Microbiol. 2010 Aug;21 Suppl C:1C-15C.

27.

Expanding access to HAART: a cost-effective approach for treating and preventing HIV.

Johnston KM, Levy AR, Lima VD, Hogg RS, Tyndall MW, Gustafson P, Briggs A, Montaner JS.

AIDS. 2010 Jul 31;24(12):1929-35. doi: 10.1097/QAD.0b013e32833af85d.

PMID:
20588171
28.

Determinants of hospitalization for a cutaneous injection-related infection among injection drug users: a cohort study.

Lloyd-Smith E, Wood E, Zhang R, Tyndall MW, Sheps S, Montaner JS, Kerr T.

BMC Public Health. 2010 Jun 9;10:327. doi: 10.1186/1471-2458-10-327.

29.

Community-associated methicillin-resistant Staphylococcus aureus is prevalent in wounds of community-based injection drug users.

Lloyd-Smith E, Hull MW, Tyndall MW, Zhang R, Wood E, Montaner JS, Kerr T, Romney MG.

Epidemiol Infect. 2010 May;138(5):713-20. doi: 10.1017/S0950268810000464. Epub 2010 Mar 5.

PMID:
20202284
30.

Impact of hepatitis C virus infection on all-cause and liver-related mortality in a large community-based cohort of inner city residents.

Grebely J, Raffa JD, Lai C, Kerr T, Fischer B, Krajden M, Dore GJ, Tyndall MW.

J Viral Hepat. 2011 Jan;18(1):32-41. doi: 10.1111/j.1365-2893.2010.01279.x.

PMID:
20196806
31.

Survival sex work involvement as a primary risk factor for hepatitis C virus acquisition in drug-using youths in a canadian setting.

Shannon K, Kerr T, Marshall B, Li K, Zhang R, Strathdee SA, Tyndall MW, Montaner JG, Wood E.

Arch Pediatr Adolesc Med. 2010 Jan;164(1):61-5. doi: 10.1001/archpediatrics.2009.241.

32.

Prevalence and structural correlates of gender based violence among a prospective cohort of female sex workers.

Shannon K, Kerr T, Strathdee SA, Shoveller J, Montaner JS, Tyndall MW.

BMJ. 2009 Aug 11;339:b2939. doi: 10.1136/bmj.b2939.

33.

Unstable housing and hepatitis C incidence among injection drug users in a Canadian setting.

Kim C, Kerr T, Li K, Zhang R, Tyndall MW, Montaner JS, Wood E.

BMC Public Health. 2009 Jul 29;9:270. doi: 10.1186/1471-2458-9-270.

34.

Piloting a peer-driven intervention model to increase access and adherence to antiretroviral therapy and HIV care among street-entrenched HIV-positive women in Vancouver.

Deering KN, Shannon K, Sinclair H, Parsad D, Gilbert E, Tyndall MW.

AIDS Patient Care STDS. 2009 Aug;23(8):603-9. doi: 10.1089/apc.2009.0022.

PMID:
19591602
35.

Determinants of cutaneous injection-related infection care at a supervised injecting facility.

Lloyd-Smith E, Wood E, Zhang R, Tyndall MW, Montaner JS, Kerr T.

Ann Epidemiol. 2009 Jun;19(6):404-9. doi: 10.1016/j.annepidem.2009.03.007. Epub 2009 Apr 11.

PMID:
19364660
36.

HIV/AIDS in Vancouver, British Columbia: a growing epidemic.

McInnes CW, Druyts E, Harvard SS, Gilbert M, Tyndall MW, Lima VD, Wood E, Montaner JS, Hogg RS.

Harm Reduct J. 2009 Mar 5;6:5. doi: 10.1186/1477-7517-6-5.

37.

Low uptake of treatment for hepatitis C virus infection in a large community-based study of inner city residents.

Grebely J, Raffa JD, Lai C, Krajden M, Kerr T, Fischer B, Tyndall MW.

J Viral Hepat. 2009 May;16(5):352-8. doi: 10.1111/j.1365-2893.2009.01080.x. Epub 2009 Feb 17.

PMID:
19226330
38.

Structural and environmental barriers to condom use negotiation with clients among female sex workers: implications for HIV-prevention strategies and policy.

Shannon K, Strathdee SA, Shoveller J, Rusch M, Kerr T, Tyndall MW.

Am J Public Health. 2009 Apr;99(4):659-65. doi: 10.2105/AJPH.2007.129858. Epub 2009 Feb 5.

39.

Risk factors for developing a cutaneous injection-related infection among injection drug users: a cohort study.

Lloyd-Smith E, Wood E, Zhang R, Tyndall MW, Montaner JS, Kerr T.

BMC Public Health. 2008 Dec 9;8:405. doi: 10.1186/1471-2458-8-405.

40.

Sexual and drug-related vulnerabilities for HIV infection among women engaged in survival sex work in Vancouver, Canada.

Shannon K, Bright V, Gibson K, Tyndall MW; Maka Project Partnership.

Can J Public Health. 2007 Nov-Dec;98(6):465-9.

PMID:
19039884
41.

Preliminary development of a scale to measure stigma relating to sexually transmitted infections among women in a high risk neighbourhood.

Rusch ML, Shoveller JA, Burgess S, Stancer K, Patrick DM, Tyndall MW.

BMC Womens Health. 2008 Nov 20;8:21. doi: 10.1186/1472-6874-8-21.

42.

Condom use among injection drug users accessing a supervised injecting facility.

Marshall BD, Wood E, Zhang R, Tyndall MW, Montaner JS, Kerr T.

Sex Transm Infect. 2009 Apr;85(2):121-6. doi: 10.1136/sti.2008.032524. Epub 2008 Sep 23.

PMID:
18812391
43.

Demographics, sexual risk behaviours and uptake of screening for sexually transmitted infections among attendees of a weekly women-only community clinic program.

Rusch ML, Shoveller JA, Burgess S, Stancer K, Patrick DM, Tyndall MW.

Can J Public Health. 2008 Jul-Aug;99(4):257-61.

PMID:
18767266
44.

Validity of self-reported adherence among injection drug users.

Kerr T, Hogg RS, Yip B, Tyndall MW, Montaner J, Wood E.

J Int Assoc Physicians AIDS Care (Chic). 2008 Jul-Aug;7(4):157-9. doi: 10.1177/1545109708320686. Epub 2008 Jul 14.

PMID:
18626123
45.

A review of barriers and facilitators of HIV treatment among injection drug users.

Wood E, Kerr T, Tyndall MW, Montaner JS.

AIDS. 2008 Jul 11;22(11):1247-56. doi: 10.1097/QAD.0b013e3282fbd1ed. Review.

PMID:
18580603
46.
47.

Nurse-delivered safer injection education among a cohort of injection drug users: evidence from the evaluation of Vancouver's supervised injection facility.

Wood RA, Wood E, Lai C, Tyndall MW, Montaner JS, Kerr T.

Int J Drug Policy. 2008 Jun;19(3):183-8. doi: 10.1016/j.drugpo.2008.01.003. Epub 2008 Mar 26.

PMID:
18367389
48.

HIV and HCV prevalence and gender-specific risk profiles of crack cocaine smokers and dual users of injection drugs.

Shannon K, Rusch M, Morgan R, Oleson M, Kerr T, Tyndall MW.

Subst Use Misuse. 2008;43(3-4):521-34. doi: 10.1080/10826080701772355.

PMID:
18365948
49.

Dermatologic manifestations of underlying infectious disease among illicit injection-drug users.

Blondin D, Crawford RI, Kerr T, Zhang R, Tyndall MW, Montaner JS, Wood E.

J Cutan Med Surg. 2008 Mar-Apr;12(2):71-6.

PMID:
18346403
50.

Drug sharing with clients as a risk marker for increased violence and sexual and drug-related harms among survival sex workers.

Shannon K, Kerr T, Bright V, Gibson K, Tyndall MW.

AIDS Care. 2008 Feb;20(2):228-34. doi: 10.1080/09540120701561270.

PMID:
18293134

Supplemental Content

Loading ...
Support Center